Medline Inc. (MDLN) shares climbed 5.2% to $34.26 as of August 22, 2026, a significant gain from the prior close of $32.58. BestStocks flagged the session as a major change for MDLN. The move is tied to price move up. Below, we break down what changed for MDLN, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
MDLN climbed 5.2% to $34.26
MDLN climbed 5.2% in its latest session, moving from $32.58 to $34.26.
Material / EarningsLow confidence
Rel. volume
0.8×
Below Avg
Vs peers
—
No comparable peers
Market cap
$29.0B
NASDAQ Global Select
Analyst target
$46
+35.2% vs price
Price chart
Jul 22 – Aug 21
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details
What it means for Medline Inc. investors
For Medline Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Material positive event; Strong 5.2% price move on light volume. Weighing against that: Medline Inc. (MDLN) moved -4.89% from $39.09 to $37.18 on 2026-07-22; Medline Inc. (MDLN) moved -3.21% from $41.11 to $39.79 on 2026-07-17. Wall Street's consensus price target sits at $46.33, implying +35.2% upside from $34.26. BestStocks rates the overall signal quality low (57/100). With earnings roughly 74 days out, the next report is the most likely near-term test of the move.
MDLN price reaction
MDLN last traded at $34.26, up $1.68 (+5.16%) from the previous close of $32.58. The session traded on 0.8× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $32.58 and $42.04, and it currently sits about 18% of the way up that band.
Bullish and bearish analyst opinions on Medline Inc. (MDLN)
The consensus analyst price target on Medline Inc. (MDLN) is $46.33, 35.2% above the recent $34.26. Over the past 90 days analysts logged 0 upgrades, 11 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MDLN line up.
▲ The bullish case
+Wall Street's consensus price target of $46.33 implies +35.2% upside from $34.26.
+The Street's most bullish target is $60.00 (+75.1%).
+Material positive event.
+Strong 5.2% price move on light volume.
+Medline Inc. (MDLN) moved +4.23% from $39.44 to $41.11 on 2026-07-16.
▼ The bearish case
−Medline Inc. (MDLN) moved -4.89% from $39.09 to $37.18 on 2026-07-22.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Aug 22, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Medline Inc. (MDLN) moved -4.04% from $33.95 to $32.58 on 2026-08-20. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The decline coincided with MDLN reaching a new 30-day low; volume remained near its 5-day average.
Material / Earnings2026-08-11+3.6%
Medline Inc. (MDLN) moved +4.10% from $33.66 to $35.04 on 2026-08-11. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on volume near its 5-day average.
Activity2026-08-10-4.0%
Medline Inc. (MDLN) moved -3.92% from $35.19 to $33.81 on 2026-08-10. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The decline marked a new 30-day low, though volume remained near its 5-day average.
Medline Inc. moved -3.90% intraday from $36.67 to $35.24. Medline Inc. (MDLN ) shares dropped over 12% following its Q2 2026 earnings report. The sell-off was driven by a 58% plunge in net income caused by a $336 million pre-tax loss from a major fire at its Tracy, California distribution center, alongside a $200 million cut to its full-year adjusted EBITDA guidance. Key Earnings Factors - Net Income Collapse: GAAP net income dropped 58.3% year-over-year to $139 million due to the distribution center fire costs, overshadowing an otherwise top-line revenue beat of $7.7 billion. - Lowered Guidance: Management slashed its full-year adjusted EBITDA outlook to a range of $3.3–$3.4 billion. - Headwinds: Investors reacted poorly to commentary regarding ongoing inflationary pressures, operational investments, and retail channel softness. You can track real-time price updates and market data directly on Yahoo Finance.If you'd like, I can provide more details on Medline's insurance recovery estimates or summarize the analyst price target revisions following the report.
Material / Earnings2026-08-05-12.8%
Medline Inc. (MDLN) reported EPS of $0.50 vs. consensus estimate of $0.35 for Q2 FY2026, beating consensus by 41.9%.
Filings2026-08-05-12.8%
Medline Inc. (MDLN) filed its 10-Q on August 5, 2026, covering recent quarterly results. Earnings are scheduled to be announced on August 6, 2026, with consensus EPS estimate of $0.32.
Material / Earnings2026-08-05-12.8%
Medline Inc. (MDLN) moved -1.70% from $37.30 to $36.66 on 2026-08-05, reaching a new 30-day low on volume 5.1x the 5-day average. We checked news, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred one day before scheduled earnings.
Material / Earnings2026-08-04+3.9%
Medline Inc. (MDLN) moved +3.73% from $40.53 to $42.04 on 2026-08-04. We checked news, earnings announcements, analyst updates, filings, and corporate actions — no company-specific catalyst was found. Volume was 1.5x the 5-day average, modestly elevated, and earnings are scheduled for announcement on 2026-08-05.
In-depth MDLN event analyses
Permanent, dated analyses of MDLN's most significant sessions.
MDLN climbed 5.2% to $34.26. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did MDLN stock rise?
MDLN gained 5.16% ($1.68) versus the prior close of $32.58, last trading at $34.26 on 0.8× average volume.
When is Medline Inc.'s next earnings date?
MDLN's next earnings report is estimated for 2026-11-04 — about 74 days away.
What is the analyst price target for MDLN?
The consensus analyst price target for MDLN is $46.33, about 35.2% above the current $34.26. Over the past 90 days, analysts recorded 0 upgrades, 11 maintains, and 0 downgrades.
How BestStocks tracks MDLN
This page is generated automatically by BestStocks' change-detection system after price move up was detected and verified against independent data sources. It draws on 19 tracked change events for MDLN, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 22, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
